Canaccord Adams initiates coverage on Hologic Inc. (Nasdaq: HOLX) with a Buy rating and $75 price target, saying the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE